Tag: orgenesis-inc

Commercial & Investment Banking Picture Gallery

Orgenesis Provides Update Regarding AIP Cell-Based Therapy for Type 1 Diabetes, MaSTherCell Cell Manufacturing Subsidiary and Overall Financial Condition

March 8, 2017
Presse

GERMANTOWN, MD -- (Marketwired) -- 03/08/17 -- (OTCQB: ), a vertically-integrated biopharmaceutical company with expertise and…

Continue Reading
Picture Gallery Venture Capital

Orgenesis Approved for Euro 12.3 Million European Grant for Further Development of Its Type 1 Diabetes Program

February 13, 2017
Presse

GERMANTOWN, MD -- (Marketwired) -- 02/13/17 -- (OTCQB: ORGS), a fully-integrated cell therapy and contract development…

Continue Reading